Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

New alliance seeks to measure tumor response to protein kinase inhibitors

Sep. 22, 2009

Halozyme Therapeutics initiates phase I clinical trial with Roche biologic

Sep. 15, 2009

Xoma and Arana Therapeutics form antibody discovery collaboration

Sep. 14, 2009

PTC Therapeutics and Roche sign drug discovery collaboration utilizing GEMS technology

Sep. 3, 2009

Nuevolution and Novartis sign drug discovery collaboration involving Chemetics

Sep. 1, 2009

Intercept Blood System for platelets receives Swiss approval

Aug. 25, 2009

Forma collaborates with Novartis on inhibitors of protein-protein interactions

Aug. 3, 2009

RXi acquires exclusive worldwide license to Advirna's RNAi delivery technology

July 30, 2009

Novartis signs agreement with Avila for Avilomics covalent drug design platform

July 29, 2009

Astellas and RegImmune sign agreement to develop new vaccine technology

July 27, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...